Neurocritical care of patients with central nervous system infections

Current Treatment Options in Neurology

Volumn 10, Issue 3, 2008, Pages 201-211

  Kramer, Andreas H ^a   Bleck, Thomas P ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; BARBITURIC ACID DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; DOPAMINE; LORAZEPAM; MANNITOL; NORADRENALIN; SEDATIVE AGENT; SODIUM CHLORIDE;

ARTIFICIAL VENTILATION; BACTERIAL MENINGITIS; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID DRAINAGE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEVER; FLUID RESUSCITATION; HEMODYNAMICS; HUMAN; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; LOW DRUG DOSE; LUMBAR PUNCTURE; PATIENT POSITIONING; REVIEW; SEDATION; SEIZURE; SEPTIC SHOCK; THERAPEUTIC HYPERVENTILATION; TRACHEOSTOMY; UNCONSCIOUSNESS; VIRUS ENCEPHALITIS;

EID: 56349086515     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-008-0022-0     Document Type: Review

References (53)

1. van de Beek D, de Gans J, Spanjaard L, et al.: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
2. Weisfelt M, van de Beek D, Spanjaard L, et al.: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol 2006, 5:123-129.
3. van de Beek D, Schmand B, de Gans J, et al.: Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002, 186:1047-1052.
4. Whitley RJ, Alford CA, Hirsch MS, et al.: Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986, 314:144-149.
5. Raschilas F, Wolff M, Delatour F, et al.: Outcome of and prognostic factors for herpes simplex encephalitis in adult patients. Clin Infect Dis 2002, 35:254-260.
6. Pepperell C, Rau N, Krajden S, et al.: West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003, 168:1399-1405.
7. Menon D: Neurocritical care: turf label, organizational construct, or clinical asset? Curr Opin Crit Care 2004, 10:91-93.
8. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354:44-53.
9. Flores-Cordero JM, Amaya-Villar R, Rincon-Ferrari MD, et al.: Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med 2003, 29:1967-1973.
10. Kennedy PC: A retrospective analysis of forty-six cases of herpes simplex encephalitis in Glasgow between 1962 and 1985. Q J Med 1988, 68:533-540.
11. Auburtin M, Porcher R, Bruneel F, et al.: Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 patients. Am J Respir Crit Care Med 2002, 165:713-717.
12. Tunkel AR, Scheld WM: Acute meningitis. In Principles and Practice of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Elsevier; 2005:1083-1126.
13. Whitley RJ, Gnann JW: Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002, 359:507-513.
14. Lindvall P, Ahlm C, Ericsson M, et al.: Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 2004, 38:384-390.
15. Barnett GH, Ropper AH, Romeo J: Intracranial pressure and outcome in adult encephalitis. J Neurosurg 1988, 68:585-588.
16. Solomon T, Dung NM, Kneen R, et al.: Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis virus. Brain 2002, 125:1084-1093.
17. Wang KW, Chang WN, Chang HW, et al.: Clinical relevance of hydrocephalus in bacterial meningitis in adults. Surg Neurol 2005, 64:61-65.
18. Diringer MN, Zazulia AR: Osmotic therapy: fact and fiction. Neurocrit Care 2004, 1:219-233.
19. Ogden AT, Mayer SA, Connolly ES Jr: Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005, 57:207-215.
20. Diringer MN, Reaven NL, Funk SE, et al.: Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 2004, 32:1489-1495.
21. Angstwurm K, Reuss S, Freyer D, et al.: Induced hypothermia in experimental pneumococcal meningitis. J Cereb Blood Flow Metab 2000, 20:834-838.
22. Schwab S, Junger E, Spranger M, et al.: Craniectomy: an aggressive approach in severe encephalitis. Neurology 1997, 48:412-417.
23. Cuthbertson BH, Dickson R, Mackenzie A: Intracranial pressure measurement, induced hypothermia and barbiturate coma in meningitis associated with intractable raised intracranial pressure. Anaesthesia 2004, 59:908-911.
24. de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549-1556.
25. Kamei S, Sekizawa T, Shiota H, et al.: Evaluation of combination therapy using acyclovir and corticosteroids in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005, 76:1544-1549.
26. Meyding-Lamade UK, Oberlinner C, Rau PR, et al.: Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 2003, 9:118-125.
27. Thompson KA, Blessing WW, Wesselingh SL: Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes encephalitis. J Neurovirol 2000, 6:25-32.
28. van Crevel H, Hijdra A, de Gans J: Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol 2002, 249:129-137.
29. Moller K, Larsen FS, Qvist J, et al.: Dependency of cerebral blood flow on mean arterial pressure in patients with acute bacterial meningitis. Crit Care Med 2000, 28:1027-1032.
30. Pfister HW, Borasio GD, Dirnagl U, et al.: Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992, 42:1497-1504.
31. Stam J: Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005, 28:1791-1798.
32. Weststrate W, Hijdra A, de Gans J: Brain infarcts in adults with bacterial meningitis. Lancet 1996, 347:399.
33. Wang KW, Chang WN, Chang HW, et al.: The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure 2005, 14:586-592.
34. Solomon T: Flavivirus encephalitis. N Engl J Med 2004, 351:370-378.
35. Bleck TP: Refractory status epilepticus. Curr Opin Crit Care 2005, 11:117-120.
36. Holtkamp M, Othman J, Buchheim K, et al.: Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76:534-539.
37. Claassen J, Mayer SA, Kowalski RG, et al.: Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004, 62:1743-1748.
38. Hamill JF, Bedford RF, Weaver DC, Colohan AR: Lidocaine before endotracheal intubation: intravenous or laryngotracheal? Anesthesiology 1981, 55:578-581.
39. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung iniury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342:1301-1308.
40. Coplin WM, Pierson DJ, Cooley KD, et al.: Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med 2000, 161:1530-1536.
41. Vallverdu I, Calaf N, Subirana M, et al.: Clinical characteristics, respiratory functional parameters, and outcome of a two-hour T-piece trial in patients weaning from mechanical ventilation. Am J Respir Crit Care Med 1998, 158:1855-1862.
42. Rivers E, Nguyen B, Havstad S, et al.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
43. Oates-Whitehead RM, Maconochie I, Baumer H, Stewart ME: Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev 2005, (3):CD004786.
44. Tureen JH, Tauber MG, Sande MA: Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest 1992, 89:947-953.
45. Richard C, Warszawski J, Anguel N, et al.: Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003, 290:2713-2720.
46. Dellinger RP, Levy MM, Carlet JM, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
47. Steiner LA, Johnston AJ, Czosnyka M, et al.: Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients. Crit Care Med 2004, 32:1049-1054.
48. Cronin L, Cook DJ, Carlet J, et al.: Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430-1439.
49. Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
50. Sprung CL, Annane D, Keh D, et al. for the CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
51. van de Beek D, de Gans J: Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004, 141:327.
52. Bernard GR, Vincent JL, Laterre PF, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
53. Vincent JL, Nadel S, Kutsogiannis DJ, et al.: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9:R331-R343.